Cargando…

Ophthalmic nepafenac use in the Netherlands and Denmark

PURPOSE: To describe nepafenac use in the Netherlands and Denmark with reference to its approved indications. For context, we also describe the use of ketorolac and diclofenac. METHODS: We identified users in the PHARMO Database Network (the Netherlands, 2008–2013) and the Danish national health reg...

Descripción completa

Detalles Bibliográficos
Autores principales:	Margulis, Andrea V, Houben, Eline, Hallas, Jesper, Overbeek, Jetty A, Pottegård, Anton, Torp‐Pedersen, Tobias, Perez‐Gutthann, Susana, Arana, Alejandro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5518196/ https://www.ncbi.nlm.nih.gov/pubmed/28493461 http://dx.doi.org/10.1111/aos.13468

Ejemplares similares

Patterns of use of antimuscarinic drugs to treat overactive bladder in Denmark, Sweden, and the United Kingdom
por: Margulis, Andrea V., et al.
Publicado: (2018)

No Evidence of Off-label Use of Olodaterol and Indacaterol in Denmark, France, and the Netherlands: A Drug Utilization Study
por: Rebordosa, Cristina, et al.
Publicado: (2020)

Topical ophthalmic NSAIDs: a discussion with focus on nepafenac ophthalmic suspension
por: Gaynes, Bruce I, et al.
Publicado: (2008)

Impact of EMA regulatory label changes on systemic diclofenac initiation, discontinuation, and switching to other pain medicines in Scotland, England, Denmark, and The Netherlands
por: Morales, Daniel R., et al.
Publicado: (2020)

Congenital Malformations in Denmark: Considerations for the Use of Danish Health Care Registries
por: Broe, Anne, et al.
Publicado: (2020)

A Case of Allergic Urticaria After Ophthalmic Nepafenac Use
por: Yaşar, Erdoğan, et al.
Publicado: (2018)

Characteristics of New Users of Aclidinium Bromide, Aclidinium/Formoterol, and Other COPD Medications in the United Kingdom, Denmark, and Germany
por: Rivero-Ferrer, Elena, et al.
Publicado: (2022)

Long-Term Risk of Skin Cancer and Lymphoma in Users of Topical Tacrolimus and Pimecrolimus: Final Results from the Extension of the Cohort Study Protopic Joint European Longitudinal Lymphoma and Skin Cancer Evaluation (JOELLE)
por: Arana, Alejandro, et al.
Publicado: (2021)

Trends of Opioid Utilisation in Denmark: A Nationwide Study
por: Nissen, Søren Kabell, et al.
Publicado: (2019)

New use of prescription drugs prior to a cancer diagnosis
por: Pottegård, Anton, et al.
Publicado: (2016)

In Vivo Pharmacokinetics of Bromfenac Ophthalmic Solution 0.075%, Bromfenac Ophthalmic Solution 0.07%, and Nepafenac/Amfenac Ophthalmic Suspension 0.3% in Rabbits
por: Sheppard, John D., et al.
Publicado: (2018)

A new likelihood model for analyses of pharmacoepidemiologic case–control studies which avoids decision rules for determining latent exposure status
por: Støvring, Henrik, et al.
Publicado: (2021)

Trends in Incidence of Intracerebral Hemorrhage and Association With Antithrombotic Drug Use in Denmark, 2005-2018
por: Hald, Stine Munk, et al.
Publicado: (2021)

Prophylactic anticoagulation with low molecular weight heparin in COVID-19: cohort studies in Denmark and Sweden
por: Lund, Lars Christian, et al.
Publicado: (2022)

Statin use and risk of nonmelanoma skin cancer: a nationwide study in Denmark
por: Arnspang, S, et al.
Publicado: (2015)

Use of proton pump inhibitors after antireflux surgery: a nationwide register-based follow-up study
por: Lødrup, Anders, et al.
Publicado: (2014)

Description of a practice model for pharmacist medication review in a general practice setting
por: Brandt, Mette, et al.
Publicado: (2014)

Children's relative age in class and use of medication for ADHD: a Danish Nationwide Study
por: Pottegård, Anton, et al.
Publicado: (2014)

Topical nepafenac in the treatment of diabetic macular edema
por: Callanan, David, et al.
Publicado: (2008)

Eyelid excoriation and erythema with nepafenac eye drop
por: Saurabh, Kumar, et al.
Publicado: (2016)

Who prescribes quetiapine in Denmark?
por: Højlund, Mikkel, et al.
Publicado: (2022)

Cardiovascular Risk in Users of Mirabegron Compared with Users of Antimuscarinic Treatments for Overactive Bladder: Findings from a Non-Interventional, Multinational, Cohort Study
por: Hoffman, Veena, et al.
Publicado: (2021)

Is urate crystal precipitation a predictor of cardiovascular risk in hyperuricemic patients? A Danish cohort study
por: Larsen, Kasper Søltoft, et al.
Publicado: (2015)

Prevalence of chronic kidney disease in the Netherlands and its cardiovascular and renal complications
por: Vervloet, Marc G., et al.
Publicado: (2023)

Impact of Urate Level on Cardiovascular Risk in Allopurinol Treated Patients. A Nested Case-Control Study
por: Søltoft Larsen, Kasper, et al.
Publicado: (2016)

The Validity of Danish Prescription Data to Measure Use of Aspirin and Other Non-Steroidal Anti-Inflammatory Drugs and Quantification of Bias Due to Non-Prescription Drug Use
por: Gaster, Natascha, et al.
Publicado: (2021)

Topical Nepafenac in Treatment of Acute Central Serous Chorioretinopathy
por: Alkin, Zeynep, et al.
Publicado: (2013)

Comparison of effect of nepafenac and diclofenac ophthalmic solutions on cornea, tear film, and ocular surface after cataract surgery: the results of a randomized trial
por: Kawahara, Atsushi, et al.
Publicado: (2016)

Efficacy of nepafenac ophthalmic suspension 0.1% in improving clinical outcomes following cataract surgery in patients with diabetes: an analysis of two randomized studies
por: Singh, Rishi P, et al.
Publicado: (2017)

Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population based cohort study
por: Pottegård, Anton, et al.
Publicado: (2021)

Validity of ICD‐9 and ICD‐10 codes used to identify acute liver injury: A study in three European data sources
por: Forns, Joan, et al.
Publicado: (2019)

Multifaceted Intervention Including Motivational Interviewing to Support Medication Adherence after Stroke/Transient Ischemic Attack: A Randomized Trial
por: Hedegaard, Ulla, et al.
Publicado: (2014)

Cox regression using a calendar time scale was unbiased in simulations of COVID-19 vaccine effectiveness & safety
por: Lund, Lars Christian, et al.
Publicado: (2023)

Bromfenac Ophthalmic Solution 0.07% Versus Nepafenac Ophthalmic Suspension 0.3% for Post-Cataract Surgery Inflammation: A Pilot Study of Identical Dosing Regimens with Pre-Surgical “Pulse” Dose
por: Silverstein, Steven M.
Publicado: (2019)

Statin Discontinuation and Cardiovascular Events Among Older People in Denmark
por: Thompson, Wade, et al.
Publicado: (2021)

Phase II placebo-controlled study of nepafenac ophthalmic suspension 0.1% for postoperative inflammation and ocular pain associated with cataract surgery in Japanese patients
por: Numaga, Jiro
Publicado: (2011)

Carbon monoxide poisoning in Denmark with focus on mortality and factors contributing to mortality
por: Simonsen, Carsten, et al.
Publicado: (2019)

Cancer Incidence after Initiation of Antimuscarinic Medications for Overactive Bladder in the United Kingdom: Evidence for Protopathic Bias
por: Kaye, James A., et al.
Publicado: (2017)

Clinical Course of Pseudophakic Cystoid Macular Edema Treated with Nepafenac
por: Aaronson, Alexander, et al.
Publicado: (2020)

Comparison of once daily dose of 0.3% nepafenac alone and three times dose of 0.1% nepafenac alone in pain and inflammation control after phacoemulsification
por: Bardoloi, Narayan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3v2inj2a6erlrbvgd79r1778mi